Target intelligence / Profile preview

HTR3E antisense RNA 1 (HTR3E-AS1)

Target
HTR3E-AS1
Molecular classification
Other (long noncoding RNA, antisense RNA)
01

Overview

HTR3E antisense RNA 1 (HTR3E-AS1) is a long noncoding antisense RNA gene transcribed from the locus opposite the HTR3E (5-hydroxytryptamine receptor 3E) gene on chromosome 3[5][3]. As with other antisense RNAs, HTR3E-AS1 is presumed to regulate gene expression of its sense counterpart (HTR3E), possibly through mechanisms such as RNA-RNA hybridization, transcriptional interference, or chromatin modification. While general functions of antisense RNAs include modulation of gene expression and involvement in epigenetic regulation, no direct link between HTR3E-AS1 and a specific human disease, drug interaction, or therapeutic use has been documented[2][5]. Antisense RNAs overall are of emerging interest in the regulation of disease genes, particularly in cancer, but HTR3E-AS1 itself is not currently considered a direct therapeutic target. Note: HTR3E-AS1 is often listed in background gene databases and should not be confused with the closely related protein-coding gene HTR3E, which encodes a serotonin receptor subunit involved in neurotransmission[4][1].

Other names
HTR3E antisense RNA 1 (non-protein coding)HTR3E-AS1
02

Biological functions

Regulation of gene expression (cis/trans regulation)Epigenetic regulationPossible involvement in chromatin modification
03

Disease associations

Potential roles in cancer (via epigenetic gene silencing through antisense mechanisms)Other (general roles of antisense RNA in disease, but not specifically assigned to HTR3E-AS1)

Beyond the preview

Go deeper on HTR3E antisense RNA 1 (HTR3E-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HTR3E antisense RNA 1 (HTR3E-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call